BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9826497)

  • 1. Conformational analysis of the first observed non-proline cis-peptide bond occurring within the complementarity determining region (CDR) of an antibody.
    Bates PA; Dokurno P; Freemont PS; Sternberg MJ
    J Mol Biol; 1998 Dec; 284(3):549-55. PubMed ID: 9826497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced conformational diversity search of CDR-H3 in antibodies: role of the first CDR-H3 residue.
    Kim ST; Shirai H; Nakajima N; Higo J; Nakamura H
    Proteins; 1999 Dec; 37(4):683-96. PubMed ID: 10651282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction.
    Oliva B; Bates PA; Querol E; Avilés FX; Sternberg MJ
    J Mol Biol; 1998 Jun; 279(5):1193-210. PubMed ID: 9642095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
    Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
    J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of the anti-c-myc antibody 9E10 Fab fragment/epitope peptide complex reveals a novel binding mode dominated by the heavy chain hypervariable loops.
    Krauss N; Wessner H; Welfle K; Welfle H; Scholz C; Seifert M; Zubow K; Aÿ J; Hahn M; Scheerer P; Skerra A; Höhne W
    Proteins; 2008 Nov; 73(3):552-65. PubMed ID: 18473392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural mechanism governing cis and trans isomeric states and an intramolecular switch for cis/trans isomerization of a non-proline peptide bond observed in crystal structures of scorpion toxins.
    Guan RJ; Xiang Y; He XL; Wang CG; Wang M; Zhang Y; Sundberg EJ; Wang DC
    J Mol Biol; 2004 Aug; 341(5):1189-204. PubMed ID: 15321715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure at 1.95 A resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognition.
    Dokurno P; Bates PA; Band HA; Stewart LM; Lally JM; Burchell JM; Taylor-Papadimitriou J; Snary D; Sternberg MJ; Freemont PS
    J Mol Biol; 1998 Dec; 284(3):713-28. PubMed ID: 9826510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting antibody complementarity determining region structures without classification.
    Choi Y; Deane CM
    Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-proline cis peptide bonds in proteins.
    Jabs A; Weiss MS; Hilgenfeld R
    J Mol Biol; 1999 Feb; 286(1):291-304. PubMed ID: 9931267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coevolution of antibody stability and Vκ CDR-L3 canonical structure.
    Luo J; Obmolova G; Huang A; Strake B; Teplyakov A; Malia T; Muzammil S; Zhao Y; Gilliland GL; Feng Y
    J Mol Biol; 2010 Oct; 402(4):708-19. PubMed ID: 20727359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDB-based protein loop prediction: parameters for selection and methods for optimization.
    van Vlijmen HW; Karplus M
    J Mol Biol; 1997 Apr; 267(4):975-1001. PubMed ID: 9135125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting antibody hypervariable loop conformations. II: Minimization and molecular dynamics studies of MCPC603 from many randomly generated loop conformations.
    Fine RM; Wang H; Shenkin PS; Yarmush DL; Levinthal C
    Proteins; 1986 Dec; 1(4):342-62. PubMed ID: 3449860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational sampling of CDR-H3 in antibodies by multicanonical molecular dynamics simulation.
    Shirai H; Nakajima N; Higo J; Kidera A; Nakamura H
    J Mol Biol; 1998 May; 278(2):481-96. PubMed ID: 9571065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of an antibody model with an X-ray structure: the variable fragment of BR96.
    Bajorath J; Sheriff S
    Proteins; 1996 Feb; 24(2):152-7. PubMed ID: 8820482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cis peptide bonds in proteins: residues involved, their conformations, interactions and locations.
    Pal D; Chakrabarti P
    J Mol Biol; 1999 Nov; 294(1):271-88. PubMed ID: 10556045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does conformational free energy distinguish loop conformations in proteins?
    Pellequer JL; Chen SW
    Biophys J; 1997 Nov; 73(5):2359-75. PubMed ID: 9370431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of chimeric antibody C2H7 Fab in complex with a CD20 peptide.
    Du J; Wang H; Zhong C; Peng B; Zhang M; Li B; Hou S; Guo Y; Ding J
    Mol Immunol; 2008 May; 45(10):2861-8. PubMed ID: 18346788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial repertoire of anti-(4-hydroxy-3-nitrophenylacetyl) antibodies as potential donors for effective affinity maturation.
    Furukawa K; Manabe A; Furukawa A; Kuba H; Okajima T; Azuma T
    Mol Immunol; 2006 Apr; 43(11):1751-60. PubMed ID: 16406527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an extended simulated annealing method: application to the modeling of complementary determining regions of immunoglobulins.
    Higo J; Collura V; Garnier J
    Biopolymers; 1992 Jan; 32(1):33-43. PubMed ID: 1617148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.